content:zonisamide

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
content:zonisamide [2020/02/13 15:53]
icna [References]
content:zonisamide [2020/02/23 22:55] (current)
icna [Zonisamide]
Line 1: Line 1:
 ====== Zonisamide ====== ====== Zonisamide ======
- +Zonisamide is a synthetic 1,2-benzisoxazole derivative (1,2-benzisoxazole-3-methanesulfonamide). It is chemically classified as a sulfonamide with a structural similarity to serotoninIt was first introduced as an AED in Japan in 1989.
-Efficacydose and mean plasma levels were similar in multi-centre studies with Japanese and Caucasian subjects[(:cite:Wroe2009>Wroe SJ. Zonisamide. In: Shorvon SPerucca E, Engel JJr, eds. The treatment of epilepsy (3nd edition). Oxford: Willey-Blackwell, 2009:713-20.)] [(:cite:Chadwick2002>Chadwick DW, Marson AGZonisamide add-on for drug-resistant partial epilepsyCochrane Database Syst Rev 2002;2:CD001416.)]. +
 ===== Authorised indications ===== ===== Authorised indications =====
  
Line 29: Line 27:
  
 **Reference range:** 15–40 mg/l (45–180 μmol/l). **Reference range:** 15–40 mg/l (45–180 μmol/l).
 +
 +see [[https://bnfc.nice.org.uk/drug/zonisamide.html|Zonisamide in the British National Formulary]]
  
 ==== Main ADRs ==== ==== Main ADRs ====
Line 76: Line 76:
  
 ==== References ==== ==== References ====
-~~refnotes cite~~+~~REFNOTES~~ 
 +~~AUTHORS~~ 
 +{{tag>pharmacopoeia}}
  • content/zonisamide.1581609204.txt.gz
  • Last modified: 24 months ago
  • by icna